|
시장보고서
상품코드
2119403
크레아틴 키나아제-Mb(CK-Mb) 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 기술별, 용도별, 최종사용자별, 검체 유형별, 지역별 - 업계 예측(2026-2033년)Creatine Kinase-Mb (Ck-Mb) Market Size, Share, and Growth Analysis, By Product Type (Reagents, Test Kits), By Technology (Immunoassay, Enzymatic Assay), By Application, By End User, By Sample Type, By Region - Industry Forecast 2026-2033 |
||||||
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모는 2024년에 5억 2,840만 달러로 평가되며, 2025년 5억 6,592만 달러에서 2033년까지 9억 7,965만 달러로 확대할 전망이며, 예측 기간(2026-2033년)에 CAGR 7.1%로 성장할 것으로 전망되고 있습니다.
전 세계 크레아틴 키나제-Mb(CK-Mb) 시장은 허혈성 심장 질환의 유병률 증가와 응급의료 분야에서 신속하고 민감한 진단 툴에 대한 수요 증가에 힘입어 성장하고 있습니다. 면역측정 기술의 발전에 따라 CK-Mb 검사는 센트럴 랩에서 현장 진단(Point-of-Care) 환경으로 전환되며, 병원 및 진료소에서의 도입이 촉진되고 있습니다. CK-Mb 검사가 트로포닌 및 미오글로빈과 함께 다항목 심장 패널에 포함됨에 따라 진단 능력이 향상되고 있으며, 이는 유리한 보험 급여 모델에 의해 지원되고 있습니다. 또한 휴대용 기기의 도입으로 진료소에서도 CK-Mb 검사를 실시할 수 있게 되어 시장 접근성이 확대되고 있습니다. AI를 활용한 진단 기술은 측정 정밀도 향상, 신속한 결과 제공, 워크플로우 효율화를 통해 이 분야에 혁명을 일으키고 있으며, 그 결과 고정밀 CK-Mb 분석법에 대한 수요를 촉진하고 시장 전체의 성장을 지원하고 있습니다.
전 세계 크레아틴 키나제-Mb(CK-Mb) 시장의 성장 요인
진단 절차에서 크레아틴 키나제-Mb(CK-Mb)의 적용이 확대되고 있는 주요 요인은 심근 손상을 특이적으로 나타내는 능력이 입증되었기 때문입니다. 이를 통해 의료진은 심장 관련 사건을 다른 의학적 문제와 더 정확하게 구별할 수 있게 됩니다. 의료진이 환자의 예후를 개선하기 위해 신뢰할 수 있는 바이오마커를 점점 더 많이 요구함에 따라 CK-Mb를 표준 검사 절차에 통합함으로써 조기 개입이 촉진되고, 불필요한 치료가 최소화되며, 병원 전반의 효율성이 향상됩니다. CK-Mb 검사에 대한 신뢰도가 높아짐에 따라 의료 기관 및 검사실에서 이러한 검사법을 더 광범위하게 도입하게 되었으며, 수요 증가와 전 세계 주요 의료 시스템에서의 보급 확대를 통해 시장 성장을 촉진하고 있습니다.
전 세계 크레아틴 키나아제-Mb(CK-Mb) 시장의 제약 요인
전 세계 크레아틴 키나제-Mb(CK-Mb) 시장은 주요 지역의 규제 당국이 부과하는 엄격한 검증 요건으로 인해 큰 제약을 받고 있습니다. 이러한 규제는 CK-Mb 진단 키트의 정확성, 재현성 및 안전성을 검증하기 위한 포괄적인 임상적 증거를 요구하고 있으며, 이로 인해 심사 과정이 장기화되고 개발 비용이 급증하고 있습니다. 이러한 상황은 특히 중소규모 제조업체의 시장 진입을 저해하고 있으며, 제품 공급 부족 및 출시 일정 지연으로 이어지고 있습니다. 그 결과, 규정 준수와 관련된 이러한 복잡성이 시장 전체의 확장에 큰 장애물이 되고 있으며, 의료 종사자들에게 신기술을 적시에 도입하는 데 방해가 되고 있습니다.
전 세계 크레아틴 키나제-Mb(CK-Mb) 시장 동향
전 세계 크레아틴 키나제-Mb(CK-Mb) 시장에서는 심근 손상의 조기 검출을 목적으로 한 고감도 분석법의 채택 확대가 두드러지는 혁신적인 동향이 나타나고 있습니다. 임상의들은 맞춤형 의료에 점점 더 집중하고 있으며, 그 결과 위험 평가를 신속하게 수행하고 환자 개개인에 맞춘 치료 전략을 실현하기 위해 CK-Mb 검사가 다중 마커 패널에 포함되고 있습니다. 이러한 진화는 다양한 환자 집단에서 CK-Mb의 예후적 중요성에 대한 인식이 높아짐에 따라 가속화되고 있습니다. 그 결과, 각 제조사들은 정밀 의학에 대한 관심이 높아지는 흐름에 발맞춰, 심혈관 질환 치료에서의 임상적 의사결정을 강화하기 위해 분석 능력을 향상시키고 효율적인 워크플로우를 실현하는 분석법 개발을 통해 혁신을 추진하고 있습니다.
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모 : 제품 유형별
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모 : 기술별
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모 : 용도별
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모 : 최종사용자별
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모 : 샘플 유형별
세계의 크레아틴 키나아제-Mb(CK-Mb) 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSAGlobal Creatine Kinase-Mb (Ck-Mb) Market size was valued at USD 528.4 Million in 2024 and is poised to grow from USD 565.92 Million in 2025 to USD 979.65 Million by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).
The global creatine kinase-Mb (CK-Mb) market is experiencing growth driven by the increasing incidence of ischemic heart disease and the rising demand for rapid, high-sensitivity diagnostic tools in emergency care. With advancements in immunoassay technology, CK-Mb testing has transitioned from centralized labs to point-of-care settings, boosting its adoption across hospitals and clinics. The integration of CK-Mb tests into multiplex cardiac panels alongside troponin and myoglobin is enhancing diagnostic capabilities, supported by favorable reimbursement models. Additionally, the introduction of portable devices enables clinics to conduct CK-Mb testing, expanding market access. AI-driven diagnostics are revolutionizing this landscape by improving measurement accuracy, providing rapid results, and facilitating workflow efficiency, thus catalyzing demand for precise CK-Mb assays and propelling overall market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Creatine Kinase-Mb (Ck-Mb) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Creatine Kinase-Mb (Ck-Mb) Market Segments Analysis
Global creatine kinase-mb (ck-mb) market is segmented by product type, technology, application, end user, sample type and region. Based on product type, the market is segmented into Reagents, Test Kits and Calibrators & Controls. Based on technology, the market is segmented into Immunoassay, Enzymatic Assay and Chemiluminescence. Based on application, the market is segmented into Myocardial Infarction Diagnosis and Cardiac Monitoring. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories and Point-of-Care Settings. Based on sample type, the market is segmented into Serum and Plasma. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Creatine Kinase-Mb (Ck-Mb) Market
The growing application of creatine kinase-Mb (CK-Mb) in diagnostic procedures is largely attributed to its established ability to specifically indicate myocardial injury, allowing healthcare professionals to discern cardiac events from other medical issues with greater precision. As medical practitioners increasingly look for reliable biomarkers to enhance patient outcomes, the incorporation of CK-Mb into standard testing practices promotes early intervention efforts, minimizes unnecessary treatments, and boosts overall hospital efficiency. This amplified trust in CK-Mb tests encourages healthcare facilities and laboratories to adopt these assays more widely, driving market growth through heightened demand and expanded reach across prominent healthcare systems worldwide.
Restraints in the Global Creatine Kinase-Mb (Ck-Mb) Market
The Global Creatine Kinase-Mb (CK-Mb) market faces significant restraints due to stringent validation requirements imposed by regulatory agencies in key regions. These regulations necessitate comprehensive clinical evidence to validate the accuracy, reproducibility, and safety of CK-Mb diagnostic kits, which extends the review process and elevates development costs. This situation particularly discourages smaller manufacturers from participating in the market, leading to limited product availability and delayed launch schedules. Consequently, this complexity in compliance serves as a major obstacle to the overall expansion of the market, thereby hindering the timely introduction of new technologies to healthcare providers.
Market Trends of the Global Creatine Kinase-Mb (Ck-Mb) Market
The Global Creatine Kinase-Mb (CK-Mb) market is witnessing a transformative trend characterized by the rising adoption of high-sensitivity assays for early detection of myocardial injury. Clinicians are increasingly focusing on personalized care approaches, leading to the integration of CK-Mb testing within multimarker panels for accelerated risk assessment and tailored therapeutic strategies. This evolution is fueled by heightened recognition of CK-Mb's prognostic significance across varied patient populations. Consequently, manufacturers are innovating by creating assays that offer improved analytical capabilities and efficient workflows, aligning with the growing momentum towards precision medicine and enhancing clinical decision-making in cardiovascular care.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Creatine Kinase-Mb (Ck-Mb) Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Reagents
- Test Kits
- Calibrators & Controls
Global Creatine Kinase-Mb (Ck-Mb) Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Immunoassay
- Enzymatic Assay
- Chemiluminescence
Global Creatine Kinase-Mb (Ck-Mb) Market Size by Application & CAGR (2026-2033)
- Market Overview
- Myocardial Infarction Diagnosis
- Cardiac Monitoring
Global Creatine Kinase-Mb (Ck-Mb) Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Laboratories
- Point-of-Care Settings
Global Creatine Kinase-Mb (Ck-Mb) Market Size by Sample Type & CAGR (2026-2033)
- Market Overview
- Serum
- Plasma
Global Creatine Kinase-Mb (Ck-Mb) Market Size & CAGR (2026-2033)
- North America (Product Type, Technology, Application, End User, Sample Type)
- US
- Canada
- Europe (Product Type, Technology, Application, End User, Sample Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Technology, Application, End User, Sample Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Technology, Application, End User, Sample Type)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Technology, Application, End User, Sample Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sekisui Diagnostics, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mindray Bio-Medical Electronics Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Snibe Diagnostic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getein Biotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wondfo Biotech Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boditech Med Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SD Biosensor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tosoh Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
